1516895-53-6 Usage
General Description
SEP-0372814 is a chemical compound that belongs to the class of pyrido[2,3-d]pyrimidines and is being studied for its potential therapeutic effects. It has been identified as a potent and selective inhibitor of cyclin dependent kinase 4 (CDK4) and cyclin dependent kinase 6 (CDK6), which are enzymes involved in cell cycle regulation. By targeting these key regulators of cell division, SEP-0372814 has shown promising anti-proliferative effects in preclinical studies, making it a potential candidate for the treatment of various cancers. Additionally, the compound has demonstrated good oral bioavailability and favorable pharmacokinetic properties, which further supports its potential as a therapeutic agent. Further research and clinical trials are needed to fully evaluate the efficacy and safety of SEP-0372814 for potential use in cancer treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 1516895-53-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,1,6,8,9 and 5 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1516895-53:
(9*1)+(8*5)+(7*1)+(6*6)+(5*8)+(4*9)+(3*5)+(2*5)+(1*3)=196
196 % 10 = 6
So 1516895-53-6 is a valid CAS Registry Number.
1516895-53-6Relevant articles and documents
HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF
-
, (2014/01/09)
Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.
